NCT06611319View on ClinicalTrials.gov

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

PHASE3RecruitingINTERVENTIONAL
Enrollment

2,932

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

July 31, 2027

Conditions
Hip Arthroplasty, TotalPrevention of Venous Thromboembolism
Interventions
DRUG

Prevention of Venous Thromboembolism

Direct oral anticoagulant

DRUG

Placebo Oral Tablet

Placebo

Trial Locations (6)

4020

RECRUITING

Kepler University Medical Center, Orthopedics and Traumatology, Linz

13589

RECRUITING

Evangelical Forest Hospital Berlin - Orthopaedics and Trauma Surgery, Berlin

16766

RECRUITING

Sana Clinics Sommerfeld, Dpt. for Surgical Orthopaedics, Kremmen

55131

RECRUITING

University Medical Center Mainz, Center for Orthopedics and Trauma Surgery, Mainz

65428

RECRUITING

GPR Rüsselsheim Health and Care Center, Rüsselsheim am Main

01307

RECRUITING

University Medical Center Dresden, University Center for Orthopaedics, Trauma & Plastic Surgery, Dresden

All Listed Sponsors
lead

Prof. Stavros Konstantinides, MD

OTHER